| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study.
|
Circulation
|
2006
|
3.62
|
|
2
|
Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study.
|
Circulation
|
2005
|
3.25
|
|
3
|
Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
|
J Am Coll Cardiol
|
2009
|
2.85
|
|
4
|
Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
|
J Am Coll Cardiol
|
2007
|
2.66
|
|
5
|
Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation.
|
Circulation
|
2005
|
2.49
|
|
6
|
Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies.
|
Circulation
|
2011
|
2.34
|
|
7
|
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
|
Arch Intern Med
|
2012
|
2.09
|
|
8
|
Endothelial progenitor cells predict long-term prognosis in patients with stable angina treated with percutaneous coronary intervention: five-year follow-up of the PROCREATION study.
|
Circ J
|
2013
|
2.02
|
|
9
|
Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
|
J Cardiovasc Med (Hagerstown)
|
2011
|
1.99
|
|
10
|
Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study.
|
JACC Cardiovasc Interv
|
2010
|
1.75
|
|
11
|
Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy.
|
J Am Coll Cardiol
|
2003
|
1.72
|
|
12
|
Comparison of access-related bleeding complications in women versus men undergoing percutaneous coronary catheterization using the radial versus femoral artery.
|
Am J Cardiol
|
2007
|
1.57
|
|
13
|
Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
|
Eur Heart J
|
2010
|
1.49
|
|
14
|
Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
|
J Am Coll Cardiol
|
2010
|
1.47
|
|
15
|
Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty.
|
Catheter Cardiovasc Interv
|
2010
|
1.43
|
|
16
|
Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
|
Am J Cardiol
|
2011
|
1.17
|
|
17
|
Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
|
Am J Cardiol
|
2007
|
1.10
|
|
18
|
Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
|
J Am Coll Cardiol
|
2006
|
1.08
|
|
19
|
Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
|
Am J Cardiol
|
2009
|
1.05
|
|
20
|
Evidence of cocaine-related coronary atherosclerosis in young patients with myocardial infarction.
|
J Am Coll Cardiol
|
2006
|
0.94
|
|
21
|
Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
|
Am J Cardiol
|
2007
|
0.93
|
|
22
|
Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
|
Am J Cardiol
|
2011
|
0.93
|
|
23
|
Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention.
|
Am J Cardiol
|
2013
|
0.91
|
|
24
|
Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study.
|
J Am Coll Cardiol
|
2011
|
0.90
|
|
25
|
Association of laryngeal cancer with previous gastric resection.
|
Ann Surg
|
2004
|
0.89
|
|
26
|
Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation.
|
Diabetes Care
|
2012
|
0.88
|
|
27
|
Optimization of the atrioventricular delay in sequential and biventricular pacing: physiological bases, critical review, and new purposes.
|
Europace
|
2012
|
0.88
|
|
28
|
C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillation.
|
Int J Cardiol
|
2009
|
0.86
|
|
29
|
High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study.
|
J Am Coll Cardiol
|
2011
|
0.85
|
|
30
|
Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study).
|
Am J Cardiol
|
2012
|
0.84
|
|
31
|
Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention.
|
Am J Cardiol
|
2005
|
0.83
|
|
32
|
Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction.
|
Clin Cardiol
|
2005
|
0.82
|
|
33
|
Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
|
Atherosclerosis
|
2009
|
0.81
|
|
34
|
Spontaneous left main coronary artery dissection.
|
Interact Cardiovasc Thorac Surg
|
2008
|
0.80
|
|
35
|
Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
|
J Thromb Thrombolysis
|
2009
|
0.80
|
|
36
|
Dexamethasone-eluting stents and plasma concentrations of adhesion molecules in patients with unstable coronary syndromes: results of the historically controlled SESAME study.
|
Clin Ther
|
2005
|
0.80
|
|
37
|
Ultrasound tissue characterization of the myocardium in patients after Kawasaki disease.
|
Pediatr Cardiol
|
2010
|
0.80
|
|
38
|
Frequency and clinical correlates of changes in Thrombolysis In Myocardial Infarction risk score during observation period at emergency department in "low-risk" patients with acute chest pain.
|
Am J Cardiol
|
2006
|
0.80
|
|
39
|
A prognostic index for risk stratification for acute heart failure and death in subjects with ischemic cardiomyopathy and cardiac defibrillator.
|
Heart Vessels
|
2015
|
0.80
|
|
40
|
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial).
|
Am J Cardiol
|
2013
|
0.79
|
|
41
|
Endothelial progenitor cells in patients with coronary artery disease and left ventricular dysfunction.
|
Coron Artery Dis
|
2009
|
0.78
|
|
42
|
C-reactive protein and risk of colon cancer.
|
JAMA
|
2004
|
0.78
|
|
43
|
A prognostic index relating 24-hour ambulatory blood pressure to cardiac events in ischemic cardiomyopathy following defibrillator implantation.
|
Pacing Clin Electrophysiol
|
2008
|
0.77
|
|
44
|
Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation.
|
Clin Res Cardiol
|
2014
|
0.77
|
|
45
|
Cumulative exercise-induced left ventricular systolic and diastolic dysfunction in hypertrophic cardiomyopathy.
|
Int J Cardiol
|
2006
|
0.77
|
|
46
|
Numbers of endothelial progenitor cells in peripheral blood are similar in younger and older patients with coronary artery disease.
|
Int J Cardiol
|
2008
|
0.76
|
|
47
|
Integrated backscatter in Becker muscular dystrophy patients with functionally normal heart: myocardial ultrasound tissue characterization study.
|
J Am Coll Cardiol
|
2006
|
0.76
|
|
48
|
Standard- vs high-dose clopidogrel after percutaneous coronary intervention.
|
JAMA
|
2011
|
0.76
|
|
49
|
320-row computed tomography coronary angiography vs. conventional coronary angiography in patients with suspected coronary artery disease: a systematic review and meta-analysis.
|
Int J Cardiol
|
2013
|
0.76
|
|
50
|
Prasugrel versus clopidogrel.
|
N Engl J Med
|
2008
|
0.76
|
|
51
|
Levosimendan allows detection of contractile reserve in patients with chronic ischaemic left ventricular dysfunction and non-diagnostic dobutamine echocardiography.
|
Eur J Heart Fail
|
2007
|
0.75
|
|
52
|
Enoxaparin in elective percutaneous coronary intervention.
|
N Engl J Med
|
2006
|
0.75
|
|
53
|
Limitations of crush technique.
|
J Am Coll Cardiol
|
2006
|
0.75
|
|
54
|
Statins and percutaneous coronary intervention.
|
Eur Heart J
|
2005
|
0.75
|
|
55
|
Coronary restenosis: a new strategy for the future?
|
Lancet
|
2007
|
0.75
|
|
56
|
Strain rate analysis and levosimendan improve detection of myocardial viability by dobutamine echocardiography in patients with post-infarction left ventricular dysfunction: a pilot study.
|
J Am Soc Echocardiogr
|
2008
|
0.75
|
|
57
|
Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) SELECT substudy.
|
J Cardiovasc Med (Hagerstown)
|
2011
|
0.75
|
|
58
|
Rationale and trial design of a randomized, controlled study on short-term psychotherapy after acute myocardial infarction: the STEP-IN-AMI trial (Short Term Psychotherapy in Acute Myocardial Infarction).
|
J Cardiovasc Med (Hagerstown)
|
2009
|
0.75
|
|
59
|
Safety and efficacy of short-term celecoxib before elective percutaneous coronary intervention for stable angina pectoris.
|
Am J Cardiol
|
2006
|
0.75
|
|
60
|
Ambulatory blood pressure monitoring early after acute myocardial infarction: development of a new prognostic index.
|
Blood Press Monit
|
2007
|
0.75
|
|
61
|
[Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
|
Ital Heart J Suppl
|
2005
|
0.75
|
|
62
|
Spheric balloon technique for ostial bifurcation lesion treatment.
|
Int J Cardiol
|
2010
|
0.75
|
|
63
|
One-year results of the randomized, controlled, short-term psychotherapy in acute myocardial infarction (STEP-IN-AMI) trial.
|
Int J Cardiol
|
2013
|
0.75
|
|
64
|
Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation).
|
Am J Cardiol
|
2013
|
0.75
|
|
65
|
A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
|
Am Heart J
|
2012
|
0.75
|
|
66
|
Treatment of left main disease with a new dedicated side-branch protection stent.
|
J Cardiovasc Med (Hagerstown)
|
2011
|
0.75
|
|
67
|
Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation.
|
Atherosclerosis
|
2013
|
0.75
|
|
68
|
Transcathether occlusion of interatrial communications: postprocedural transoesophageal echocardiography allows timely detection and treatment of intracardiac thrombus formation.
|
Eur J Echocardiogr
|
2008
|
0.75
|
|
69
|
Effects of reperfusion obtained two to six months after acute myocardial infarction on myocardial electrical stabilization in patients with an occluded infarct-related coronary artery.
|
Am J Cardiol
|
2005
|
0.75
|
|
70
|
Time course, predictors and clinical implications of stent thrombosis following primary angioplasty. Insights from the DESERT cooperation.
|
Thromb Haemost
|
2013
|
0.75
|
|
71
|
[Atrioventricular asynchrony and pacing].
|
G Ital Cardiol (Rome)
|
2010
|
0.75
|
|
72
|
Randomized study on provisional stenting with sirolimus-eluting stent vs. bare metal stent for the treatment of true coronary bifurcations: the PROSUMER (PROvisional with sirolimus-eluting vs. bare metal stents in truE bifuRcations) study.
|
Int J Cardiol
|
2010
|
0.75
|
|
73
|
Visualization of coronary arteries and coronary stents by low dose 320-slice multi-detector computed tomography in a patient with atrial fibrillation.
|
Int J Cardiol
|
2010
|
0.75
|
|
74
|
A uncommon cause of angina during upper limb exercise.
|
Ital Heart J
|
2004
|
0.75
|
|
75
|
Methylenetetrahydrofolate reductase (MTHFR) C677T genetic polymorphism and late infarct-related coronary artery patency after thrombolysis.
|
J Thromb Thrombolysis
|
2008
|
0.75
|
|
76
|
Pain perception during esophageal warming due to radiofrequency catheter ablation in the left atrium.
|
J Interv Card Electrophysiol
|
2009
|
0.75
|